WallStSmart
BDX

Becton Dickinson and Company

NYSE: BDX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$143.15
+1.07% today

Updated 2026-06-05

Market cap
$39.80B
P/E ratio
25.21
P/S ratio
1.79x
EPS (TTM)
$5.73
Dividend yield
2.88%
52W range
$126 – $186
Volume
2.9M

Becton Dickinson and Company (BDX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$5.74B$6.36B$7.07B$6.99B$7.12B$7.58B$7.71B$8.05B$8.45B$10.28B$12.48B$12.09B$15.98B$17.29B$16.07B$19.13B$18.87B$19.37B$20.18B$21.84B
Revenue growth (YoY)+10.8%+11.2%-1.2%+2.0%+6.5%+1.6%+4.5%+4.9%+21.7%+21.4%-3.1%+32.2%+8.2%-7.0%+19.0%-1.4%+2.7%+4.2%+8.2%
Cost of revenue$2.79B$3.07B$3.45B$3.31B$3.43B$3.63B$3.75B$3.88B$4.14B$5.59B$6.49B$6.13B$8.71B$9.00B$9.28B$10.50B$10.39B$11.20B$11.05B$11.91B
Gross profit$2.94B$3.29B$3.63B$3.68B$3.70B$3.96B$3.95B$4.17B$4.30B$4.70B$5.99B$5.96B$7.27B$8.29B$6.80B$8.63B$8.48B$8.17B$9.13B$9.92B
Gross margin51.3%51.7%51.3%52.6%51.9%52.2%51.3%51.8%50.9%45.7%48.0%49.3%45.5%47.9%42.3%45.1%44.9%42.2%45.2%45.4%
R&D$301.87M$360.05M$395.63M$404.57M$422.77M$470.00M$472.00M$494.00M$550.00M$632.00M$828.00M$770.00M$1.00B$1.06B$1.04B$1.28B$1.26B$1.24B$1.19B$1.26B
SG&A$1.54B$1.60B$1.72B$1.70B$1.72B$1.85B$1.92B$2.42B$2.15B$2.56B$3.00B$44.00M$13.00M$2.00M$7.00M$1.00M$4.71B$4.72B$4.86B$5.28B
Operating income$1.14B$1.20B$1.54B$1.59B$1.58B$1.67B$1.56B$1.25B$1.61B$1.07B$1.43B$1.52B$1.51B$1.76B$912.00M$2.25B$2.28B$2.11B$2.40B$2.58B
Operating margin19.9%18.9%21.7%22.8%22.2%22.0%20.2%15.6%19.0%10.4%11.5%12.6%9.4%10.2%5.7%11.8%12.1%10.9%11.9%11.8%
EBITDA$1.60B$1.77B$2.05B$2.08B$2.11B$2.20B$2.12B$1.85B$2.22B$2.00B$2.58B$2.58B$3.86B$4.07B$3.06B$4.39B$4.41B$4.40B$4.82B$4.96B
EBITDA margin27.8%27.8%29.0%29.8%29.6%29.0%27.5%23.0%26.3%19.5%20.6%21.4%24.1%23.5%19.0%23.0%23.4%22.7%23.9%22.7%
EBIT$1.19B$1.33B$1.57B$1.62B$1.62B$1.70B$1.61B$1.30B$1.66B$1.11B$1.46B$1.50B$1.88B$1.81B$942.00M$2.16B$2.18B$2.11B$2.53B$2.50B
Interest expense$0.00$0.00$36.34M$40.39M$51.26M$84.00M$135.00M$138.00M$135.00M$371.00M$388.00M$521.00M$706.00M$639.00M$528.00M$469.00M$398.00M$452.00M$528.00M$613.00M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$752.28M$890.03M$1.13B$1.23B$1.32B$1.27B$1.17B$1.29B$1.19B$695.00M$976.00M$1.10B$311.00M$1.23B$874.00M$2.09B$1.78B$1.48B$1.71B$1.68B
Net income growth (YoY)+18.3%+26.6%+9.3%+7.0%-3.5%-7.9%+10.5%-8.4%-41.4%+40.4%+12.7%-71.7%+296.5%-29.1%+139.4%-15.0%-16.6%+14.9%-1.6%
Profit margin13.1%14.0%15.9%17.6%18.5%16.8%15.2%16.1%14.0%6.8%7.8%9.1%1.9%7.1%5.4%10.9%9.4%7.7%8.4%7.7%

Frequently asked questions

What is Becton Dickinson and Company's revenue?

Becton Dickinson and Company's trailing twelve-month revenue is $22.23B, and consensus projects about $24.31B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is BDX?

In its most recent fiscal year, BDX ran a gross margin of 45.44%, an operating margin of 11.80%, and a net margin of 7.68%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does BDX generate?

BDX produced $2.67B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BDX's balance sheet healthy?

BDX holds $851.00M in cash and equivalents against $17.62B in long-term debt, on $25.39B of shareholder equity. That debt is best read against the cash flow the business throws off each year.